Advagene Biopharma Co., Ltd. (6709)
Market Closed
16 Oct, 05:30 AM
TWSE 
JPX Primary TWSE NT$
25. 00
+0.75
+3.0928%
NT$
- Market Cap
- P/E Ratio
- Div Yield
1,001 Volume
- Eps
NT$ 24.25
Previous Close Want to track 6709 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Advagene Biopharma Co., Ltd. (6709) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.38B
Trailing P/E (ttm) -15.86
Forward P/E -
PEG ratio 0.6
Price/Sales (ttm) -
Price/Book (mrq) 4.08
Enterprise Value/Revenue -
Enterprise Value/EBITDA -15.56
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 31.35K
Average volume (90 days) 51.66K
Price summary
52-Week low 22.5
52-Week high 36.5
Beta -
50-Day moving average 24.72
200-Day moving average 25.32
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.25%
Return on equity -0.36%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.5
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.35
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 44.32%
Book value per share (mrq) 5.87
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
